449 related articles for article (PubMed ID: 9252796)
1. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
[TBL] [Abstract][Full Text] [Related]
2. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
3. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
4. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of tolfenamic acid in the prevention of migraine].
Vaitkus A; Pauza V
Medicina (Kaunas); 2002; 38(3):296-303. PubMed ID: 12474702
[TBL] [Abstract][Full Text] [Related]
6. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
[TBL] [Abstract][Full Text] [Related]
7. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
[TBL] [Abstract][Full Text] [Related]
8. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
Diamond S; Elkind A; Jackson RT; Ryan R; DeBussey S; Asgharnejad M
Arch Fam Med; 1998; 7(3):234-40. PubMed ID: 9596457
[TBL] [Abstract][Full Text] [Related]
9. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
Géraud G; Valette C
Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
Bousser MG; D'Allens H; Richard A
J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474
[TBL] [Abstract][Full Text] [Related]
11. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of nimodipine in comparison with pizotifen in the prophylaxis of migraine.
Havanka-Kanniainen H; Hokkanen E; Myllylä VV
Cephalalgia; 1987 Mar; 7(1):7-13. PubMed ID: 3555838
[TBL] [Abstract][Full Text] [Related]
13. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
[TBL] [Abstract][Full Text] [Related]
14. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan.
Pfaffenrath V; Cunin G; Sjonell G; Prendergast S
Headache; 1998 Mar; 38(3):184-90. PubMed ID: 9563208
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
Carpay J; Schoenen J; Ahmad F; Kinrade F; Boswell D
Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
18. Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study.
Tfelt-Hansen P; Bach FW; Daugaard D; Tsiropoulos I; Riddersholm B
J Headache Pain; 2006 Dec; 7(6):389-94. PubMed ID: 17164991
[TBL] [Abstract][Full Text] [Related]
19. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
20. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
